NCT06839391 Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CS Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05995626 Hyaluronidase Via LADD Scleroderma-induced Microstomia Status COMPLETED Phase EARLY_PHASE1
NCT05671172 Effect of Adding Hyaluronidase to Bupivacaine in Transversus Abdominis Plane Block for Cesarean Section Status COMPLETED Phase NA
NCT05498220 Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma Status TERMINATED Phase PHASE2
NCT05083663 Effectiveness of Adding Hyaluronidase to Bupivacaine in Ultrasound Guided Supraclavicular Brachial Plexus Block Status UNKNOWN Phase PHASE2/PHASE3
NCT03411330 Safety and Efficacy of Addition of Hyaluronidase to Lidocaine and Bupivacaine in Scalp Nerves Block in Elective Craniotomy Operations, Comparative Study Status COMPLETED Phase EARLY_PHASE1
NCT03306615 Peripheral Modulation of Muscle Stiffness and Spasticity Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02059694 Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's Surgery Status WITHDRAWN Phase NA
NCT01945099 Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy Status COMPLETED Phase EARLY_PHASE1
NCT01722916 Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT01719978 Hemodynamic and Electrocardiographic Effects of Hyaluronidase Associated With Local Anaesthetics Status COMPLETED Phase PHASE4
NCT01689363 Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP) Status COMPLETED Phase PHASE2
NCT00000493 Multicenter Investigation of Limitation of Infarct Size (MILIS) Status COMPLETED Phase PHASE3